Stretch, Injury and Inflammation Markers Evaluation to Predict Clinical Outcomes After Implantable Cardioverter Defibrillator Therapy in Heart Failure Patients With Metabolic Syndrome
Background: Internal cardioverter defibrillator (ICD) therapy reduced all-cause mortality. Conversely, few studies reported that ICDs' shocks may reduce survival. Recently authors suggested that, multiple inflammatory and molecular pathways were related to worse prognosis in metabolic syndrome...
Main Authors: | Celestino Sardu, Raffaele Marfella, Matteo Santamaria, Stefano Papini, Quintino Parisi, Cosimo Sacra, Daniele Colaprete, Giuseppe Paolisso, Maria R. Rizzo, Michelangela Barbieri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2018.00758/full |
Similar Items
-
Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
by: Thienel M, et al.
Published: (2022-11-01) -
“Carryover phenomenon” in subcutaneous implantable cardioverter‐defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia
by: Yasunobu Yamagishi, et al.
Published: (2022-06-01) -
Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01) -
The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01) -
Cost-Effectiveness of Cardioverter-Defibrillator Implantation in Kazakhstan
by: Begisbayev T, et al.
Published: (2022-10-01)